3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Hypotension in 1 studies
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawahara, Y | 1 |
| Kawahara, H | 1 |
| Westerink, BH | 1 |
1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Hypotension
| Article | Year |
|---|---|
Hypotension-induced dopamine release in prefrontal cortex is mediated by local glutamatergic projections at the level of nerve terminals.
Topics: Animals; Dopamine; Excitatory Amino Acid Antagonists; Glutamic Acid; Handling, Psychological; Hypote | 2002 |